More than 200,000 Australians who are immunocompromised will gain free access to the shingles vaccine in an expansion of a ...

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

Follow today’s news live. What we learned, 22 September 2024 06:56 With that we’re wrapping up the blog. Before ...

Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines. The recombinant herpes zoster (shingles) vaccine is ...

GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older. The British pharma giant ...

(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage ...

With sales of its flagship shingles vaccine Shingrix separately faltering, new data on co-administration of the two adult vaccines could provide a new way for the company to promote the jabs.

A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk KUALA LUMPUR, Malaysia, Sept. 13, 2024 /PRNewswire/ -- GlaxoSmithKline ...

GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed vaccines — RSV vaccine Arexvy and shingles vaccine Shingrix — in ...